Enrolling by Invitation
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
NCT06810895
- Conditions
- Cadonilimab, Cervix Cancer, Female Urogenital Diseases, +13 more
- Locations
-
- ongji Hospital, Tongji Medical College, Huazhong University of Science andTechnology Wuhan, China